Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9097 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD7819 |
Suspended |
0.8859 |
High Similarity |
NPD2534 |
Approved |
0.8859 |
High Similarity |
NPD2533 |
Approved |
0.8859 |
High Similarity |
NPD2532 |
Approved |
0.8733 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8591 |
High Similarity |
NPD3750 |
Approved |
0.8571 |
High Similarity |
NPD7473 |
Discontinued |
0.85 |
High Similarity |
NPD6232 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8387 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8367 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8365 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8365 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8322 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8301 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8291 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8267 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8255 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8255 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8231 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8228 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.82 |
Intermediate Similarity |
NPD2796 |
Approved |
0.82 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.82 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8176 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD5711 |
Approved |
0.816 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8125 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8113 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8101 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD920 |
Approved |
0.8 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7949 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7898 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7866 |
Intermediate Similarity |
NPD919 |
Approved |
0.7852 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7852 |
Intermediate Similarity |
NPD411 |
Approved |
0.7847 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7843 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7843 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7843 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7843 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7824 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7751 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7688 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7687 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7677 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD7003 |
Approved |
0.763 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD17 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7582 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7576 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD943 |
Approved |
0.75 |
Intermediate Similarity |
NPD3764 |
Approved |
0.75 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7374 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7374 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD37 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7329 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7204 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6779 |
Approved |
0.72 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7143
|
Intermediate Similarity |
NPD3751 |
Discontinued |